FDC Ltd has announced about the following:
1. Forbes Asia October 2006 issue has ranked the Company as one of the 200 "Best under a Billion Companies" with sales of less than $1 billion with solid top and bottom line gains and potentials for more success.
2. The Company has entered into a non-exclusive license agreement with GILEAD Sciences Inc., for production and distribution of Tenofovir Disoproxil Fumarate (tenofovir DF) to 95 low-income countries around the world, including India. Tenofovir DF is sold by Gilead under the brand name Viread (R) in addition, this agreement also allows the manufacture of commercial quantities of both active pharmaceutical ingredient (API) and finished product.